ProCE Banner Activity

PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape

Podcast Episodes
Listen to Philip Agop Philip, MD, PhD, FRCP, and Elena Gabriela Chiorean, MD, discuss the role of testing for biomarkers and the current paradigm of PARP inhibitor therapy in the treatment of pancreatic cancer.

Released: October 26, 2021

Expiration: October 25, 2022

No longer available for credit.



Gabriela Hobbs

Gabriela Hobbs, MD

Assistant Professor
Clinical Director
, Leukemia
Division of Leukemia
Department of Medicine
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by an educational grant from